SEARCH
Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says
NDTV Profit
2022-02-26
Views
4
Description
Share / Embed
Download This Video
Report
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x88agzz" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:00
Laurus Labs In Focus | Ask Profit | NDTV Profit
23:30
Q1 Review | Laurus Labs' Founder Shares Earnings Insights
23:30
Q3 Review| Laurus Labs Growth Strategies For Coming Quarters
27:08
Q2 Review: Laurus Labs' Profit Nosedives 84% In Second Quarter
12:41
Laurus Labs Forays Into Biotech Segment Via Acquisition
26:27
Laurus Labs In Focus | Ask Profit | NDTV Profit
03:23
Ideas for Profit | Laurus Labs - a diversified portfolio of APIs and formulations.
35:10
Talking Point With Laurus Labs' Satyanarayana Chava
00:00
Laurus Labs In Focus | Profit Insight | NDTV Profit
26:05
Q4 Review: Laurus Labs' Plans To Accelerate Growth In FY23
20:29
Laurus Labs Management On Q1 Report Card & More
03:18
Margins Lower On R&D Spends: Laurus Labs
